Two specific probiotic strains, Lactiplantibacillus plantarum LP5 and BX62, reduced liver damage and fat accumulation in rats with fatty liver disease caused by high-fat diets, according to a 2026 research study. The LP5 strain was particularly effective at managing cholesterol metabolism, while the BX62 strain excelled at protecting cells from oxidative damage. When combined, both strains activated cellular pathways that reduced fat storage and increased fat burning in the liver.
Researchers tested two types of beneficial bacteria called Lactiplantibacillus plantarum on rats with fatty liver disease caused by eating high-fat, high-cholesterol diets. According to Gram Research analysis, both bacterial strains helped reduce liver damage, but in different ways: one strain was better at managing cholesterol, while the other excelled at fighting harmful molecules that damage cells. When combined, these probiotics activated the body’s natural cleanup systems and reduced fat buildup in the liver. The findings suggest these specific probiotic strains could potentially help people protect their liver health, though human studies are still needed to confirm the benefits.
Key Statistics
A 2026 research article found that Lactiplantibacillus plantarum LP5 strain reduced hepatic fat accumulation and weight gain more effectively than the BX62 strain in rats fed high-fat, high-cholesterol diets.
According to research reviewed by Gram, the BX62 probiotic strain activated the Nrf2-HO-1 antioxidant defense pathway, providing enhanced protection against cellular oxidative damage in fatty liver disease.
A 2026 animal study demonstrated that combining both Lactiplantibacillus plantarum strains (LP5 and BX62) activated AMPK signaling, which decreased fat-producing proteins (SREBP-1c, FASN, and SCD1) while increasing fat-burning proteins (PPARα and CPT1a).
Research published in 2026 showed that both probiotic strains reduced intestinal permeability and inflammation markers in rats with diet-induced fatty liver disease, suggesting improved gut barrier function.
The Quick Take
- What they studied: Whether two specific probiotic bacteria strains could reduce liver damage and fatty liver disease in rats fed unhealthy diets high in fat and cholesterol
- Who participated: Laboratory rats that were fed high-fat, high-cholesterol diets to develop fatty liver disease similar to the human condition
- Key finding: Both probiotic strains reduced liver damage and fat accumulation, with one strain (LP5) being particularly effective at managing cholesterol and the other (BX62) better at protecting against cellular damage from harmful molecules
- What it means for you: These findings suggest specific probiotics might help protect liver health, but this is early-stage research in animals. People with fatty liver disease should consult their doctor before trying new supplements, as human studies are needed to confirm safety and effectiveness
The Research Details
Researchers conducted an animal study using rats to test two specific probiotic bacteria strains. They fed some rats a high-fat, high-cholesterol diet to create fatty liver disease, similar to what happens in humans with poor diets. Different groups of rats received either the first probiotic strain (LP5), the second strain (BX62), both strains combined, or no probiotics. The researchers then examined the rats’ livers and blood to measure how much fat accumulated, how much damage occurred, and which cellular systems were activated or changed.
This type of study is important because it allows scientists to carefully control all variables and directly examine liver tissue under a microscope. Animal studies help researchers understand how treatments work at the cellular level before testing them in humans. The researchers measured multiple markers of liver health, including fat content, inflammation, and the activity of specific proteins involved in cholesterol and fat metabolism.
The study examined both the physical changes in the liver and the molecular mechanisms, meaning the researchers looked at which genes and proteins were activated by the probiotics. This detailed approach helps explain not just whether the probiotics worked, but how they worked.
Understanding how probiotics affect liver disease at the molecular level is crucial because it helps scientists design better treatments and predict which patients might benefit most. This research matters because fatty liver disease is increasingly common worldwide and currently has limited treatment options beyond lifestyle changes. By identifying specific probiotic strains and their mechanisms of action, researchers can develop targeted dietary interventions that might prevent disease progression.
This is a controlled laboratory study, which means researchers could carefully manage all conditions and directly examine liver tissue. However, because it was conducted in rats rather than humans, the results may not directly apply to people. The study measured multiple markers of liver health and examined the molecular mechanisms, which strengthens confidence in the findings. The research was published in a peer-reviewed journal focused on probiotics, suggesting it met scientific standards for publication. Readers should note that animal studies are typically early-stage research and serve as a foundation for future human trials.
What the Results Show
Both probiotic strains successfully reduced liver damage and fatty liver disease in rats fed unhealthy diets. The rats receiving probiotics showed significantly less fat accumulation in their livers compared to control rats. Additionally, the probiotics reduced markers of liver injury and inflammation, suggesting they protected liver cells from damage.
The two strains worked through different but complementary mechanisms. The LP5 strain was particularly effective at managing cholesterol metabolism by activating specific proteins involved in bile acid production and cholesterol breakdown. This strain also showed the greatest reduction in weight gain and liver fat accumulation. The BX62 strain excelled at activating the body’s natural antioxidant defense system, which protects cells from damage caused by harmful molecules called free radicals.
When both strains were combined, they activated a cellular energy sensor called AMPK that helps regulate fat metabolism. This activation led to decreased production of new fat molecules and increased breakdown of existing fat. The probiotics also reduced the activity of proteins that promote fat storage while increasing proteins that burn fat for energy.
All three intervention strategies (LP5 alone, BX62 alone, and both combined) improved the overall health of liver tissue and reduced intestinal permeability, meaning the gut barrier functioned better and fewer harmful substances leaked into the bloodstream.
The research revealed that the probiotics improved intestinal barrier function, which is important because a leaky gut can worsen liver disease. The probiotics also reduced inflammation markers throughout the body, not just in the liver. The study found that the LP5 strain was more effective at reducing overall weight gain in the rats, suggesting it may have broader metabolic benefits beyond just liver protection. The BX62 strain’s activation of the antioxidant defense system was particularly notable because oxidative stress is a major driver of liver disease progression.
This research builds on previous studies showing that probiotics can help with liver health, but it provides more detailed information about how specific strains work. Earlier research suggested probiotics might help with fatty liver disease, but this study identifies two specific strains and explains their distinct mechanisms of action. The finding that different probiotic strains work through different pathways (cholesterol metabolism versus antioxidant defense) is consistent with emerging research showing that probiotic effects are strain-specific rather than class-wide. This study adds to growing evidence that probiotics are not all the same and that selecting the right strain matters for specific health conditions.
This study was conducted in rats, not humans, so the results may not directly translate to people. The sample size of rats was not specified in the available information, making it difficult to assess statistical power. The study used a specific diet model that may not perfectly replicate all aspects of human fatty liver disease. The research was conducted in a controlled laboratory setting, whereas real-world factors like stress, sleep, and exercise variation were not included. Additionally, the study examined short-term effects, so it’s unclear whether the benefits would persist long-term or whether the probiotics would work in people with existing liver disease. Human clinical trials are needed to confirm these findings and determine appropriate dosages for people.
The Bottom Line
Based on this animal research, these specific probiotic strains show promise for supporting liver health, but the evidence is preliminary. People interested in probiotics for liver health should consult their healthcare provider before starting supplements. Current evidence supports maintaining a healthy diet low in saturated fat and cholesterol as the primary strategy for preventing fatty liver disease. If probiotics are considered, choosing strains that have been specifically studied for liver health may be more effective than generic probiotic supplements. Confidence level: Low to moderate, as this is animal research requiring human confirmation.
People with fatty liver disease or those at risk due to obesity, diabetes, or metabolic syndrome should be most interested in this research. Healthcare providers treating liver disease may find this information useful for understanding potential dietary interventions. People considering probiotic supplements for general health should understand that not all probiotics work the same way. This research is less relevant for people with healthy livers or those without metabolic risk factors, though maintaining good liver health through diet is beneficial for everyone.
In the rat study, benefits appeared within the timeframe of the experiment, but the exact duration was not specified. If these findings translate to humans, benefits would likely take weeks to months to appear, as metabolic changes typically occur gradually. People should not expect immediate results and should maintain consistent use of any probiotic supplement for at least 8 to 12 weeks before assessing effectiveness. Long-term use may be necessary to prevent disease progression.
Frequently Asked Questions
Can probiotics help with fatty liver disease?
Animal research shows specific probiotic strains like Lactiplantibacillus plantarum LP5 and BX62 reduced liver fat and damage in rats. However, human studies are needed to confirm effectiveness. Consult your doctor before using probiotics as a treatment for fatty liver disease.
Which probiotic strain is better for liver health?
According to 2026 research, LP5 excels at cholesterol management and reducing liver fat, while BX62 is superior at fighting cellular damage through antioxidant activation. The best choice depends on your specific liver health needs and should be discussed with your healthcare provider.
How long does it take for probiotics to improve liver health?
The animal study showed benefits within the experimental timeframe, but human studies haven’t established a clear timeline. Metabolic changes typically require 8 to 12 weeks of consistent use. Results vary by individual, and long-term monitoring through blood tests is recommended.
Are all probiotics the same for liver disease?
No. Research shows different probiotic strains work through different mechanisms. The specific strains LP5 and BX62 studied here worked through cholesterol metabolism and antioxidant pathways respectively. Generic probiotics may not provide the same liver-protective benefits.
What diet changes should accompany probiotic use for liver health?
Reducing saturated fat and cholesterol intake is essential, as the study used high-fat, high-cholesterol diets to create liver disease. Probiotics work best alongside dietary improvements. Consult a nutritionist or doctor for personalized dietary recommendations for your liver health.
Want to Apply This Research?
- Track daily probiotic supplement intake and measure liver health markers through periodic blood tests (ALT, AST, and triglyceride levels) every 3 months to monitor changes over time
- Add a daily probiotic supplement containing Lactiplantibacillus plantarum strains to your routine, paired with dietary improvements like reducing saturated fat and cholesterol intake, and log both behaviors in the app to maintain consistency
- Create a monthly check-in to assess energy levels, digestive health, and weight trends while tracking supplement adherence. Schedule quarterly lab work reminders to monitor liver function tests and share results with your healthcare provider through the app
This article summarizes animal research and is for educational purposes only. The findings have not been tested in humans. Fatty liver disease is a serious medical condition that requires professional diagnosis and treatment. Do not use probiotics as a substitute for medical care or prescribed treatments. Before starting any probiotic supplement, especially if you have liver disease, diabetes, or other health conditions, consult your healthcare provider. Individual results may vary, and probiotics are not regulated by the FDA in the same way as medications. Always discuss dietary supplements with your doctor before use.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.